Wandong Medical Valuation Multiples

Wandong Medical is valued at $1.1B as of October 2026, a 2.8x revenue multiple. In the last 12 months, Wandong Medical revenue was $227M.

Wandong Medical Overview

About Wandong Medical

Beijing Wandong Medical Technology Co Ltd is engaged in the development, manufacture, and distribution of medical equipment. Its products consist of radiological imaging equipment, including angiographic and cardiac systems, digital direct radiography (DR) imaging equipment, high frequency diagnostic systems, high frequency radiographic systems, conventional x-ray diagnostic equipment and high frequency mobile units, magnetic resonance imaging (MRI) equipment, as well as digital medical image management systems, among others. The company is also engaged in providing maintenance services.


Founded

1997

HQ

China

Employees

964

Financials (LTM)

Revenue: $227M
Net Income: ($11M)

EV

$643M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Wandong Medical Financials

Wandong Medical reported last 12-month revenue of $227M.

In the same LTM period, Wandong Medical generated $61M in gross profit and had net loss of ($11M).

Revenue (LTM)


Wandong Medical P&L

In the most recent fiscal year, Wandong Medical reported revenue of $202M and EBITDA of ($46M).

Wandong Medical is unprofitable as of last fiscal year, with gross margin of 27%, EBITDA margin of (23%), and net margin of (17%).

See analyst estimates for Wandong Medical
LTMLast FY202320242025202620272028
Revenue$227M$202M$183M$226M$202M
Gross Profit$61M$54M$78M$83M$54M
Gross Margin27%27%42%37%27%
EBITDA-($46M)$37M$31M($46M)
EBITDA Margin-(23%)20%14%(23%)
EBIT Margin(5%)(20%)8%8%(20%)
Net Profit($11M)($34M)$28M$23M($34M)
Net Margin(5%)(17%)15%10%(17%)
Net Debt-($485M)---

Financial data powered by Morningstar, Inc.

Wandong Medical Stock Performance

Wandong Medical has current market cap of $1.1B, and enterprise value of $643M.

Market Cap Evolution


Wandong Medical's stock price is $1.51.

Wandong Medical share price decreased by 4.2% in the last 30 days, and by 32.2% in the last year.

Wandong Medical has an EPS (earnings per share) of $-0.05.

See more trading valuation data for Wandong Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$643M$1.1B-0.4%-4.2%-10.1%-32.2%$-0.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Wandong Medical Valuation Multiples

Wandong Medical trades at 2.8x EV/Revenue multiple, and (14.0x) EV/EBITDA.

See NTM and 2027E valuation multiples for Wandong Medical

EV / Revenue (LTM)


Wandong Medical Financial Valuation Multiples

As of October 17, 2026, Wandong Medical has market cap of $1.1B and EV of $643M.

Wandong Medical has a P/E ratio of (100.4x).

LTMLast FY202320242025202620272028
EV/Revenue2.8x3.2x3.5x2.8x3.2x
EV/EBITDA-(14.0x)17.3x20.9x(14.0x)
EV/EBIT(53.9x)(15.7x)43.2x37.9x(15.7x)
EV/Gross Profit10.6x12.0x8.3x7.8x12.0x
P/E(100.4x)(31.2x)38.1x45.6x(31.2x)
EV/FCF-(12.2x)22.7x24.1x(12.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Wandong Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Wandong Medical Margins & Growth Rates

Wandong Medical grew revenue by 17% but net profit decreased by 86% in the last fiscal year.

In the most recent fiscal year, Wandong Medical reported gross margin of 27%, EBITDA margin of (23%), and net margin of (17%).

See estimated margins and future growth rates for Wandong Medical

Wandong Medical Margins

Last FY202420252026202720282029
Gross Margin27%37%27%27%
EBITDA Margin(23%)14%(23%)-
EBIT Margin(20%)8%(20%)(2%)
Net Margin(17%)10%(17%)(2%)
FCF Margin(26%)12%(26%)-

Wandong Medical Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth17%23%(11%)17%
Gross Profit Growth17%6%(35%)17%
EBITDA Growth-(17%)(249%)-
EBIT Growth(91%)14%(341%)(91%)
Net Profit Growth(86%)(17%)(246%)(86%)
FCF Growth-(6%)(297%)-

Data powered by FactSet, Inc. and Morningstar, Inc.

Wandong Medical Operational KPIs

Wandong Medical's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for Wandong Medical
LTMLast FY202320242025202620272028
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue14%6%7%4%6%
G&A Expenses to Revenue5%2%2%2%2%
R&D Expenses to Revenue13%20%13%11%20%
Opex to Revenue-47%34%29%47%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Wandong Medical Competitors

Wandong Medical competitors include Staar Surgical, Artivion, Lumexa Imaging, PHC Holdings, Integra Lifesciences, Guangzhou Wondfo Biotech, PROCEPT BioRobotics, iRadimed, Enovis and Tandem Diabetes Care.

Most Wandong Medical public comparables operate across Medical Devices, Medical Imaging & Diagnostics, DeepTech and HealthTech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Staar Surgical$239M($37M)3.8x2.9x(24.7x)19.2x
Artivion$441M$63M3.2x2.9x22.1x14.8x
Lumexa Imaging$1B$142M1.9x1.8x13.7x8.2x
PHC Holdings$2.3B$315M1.0x1.0x7.1x6.2x
Integra Lifesciences$1.6B($344M)1.7x1.7x(8.2x)8.6x
Guangzhou Wondfo Biotech$312M$26M2.9x2.9x34.6x12.7x
PROCEPT BioRobotics$308M($98M)2.8x2.3x(8.8x)(23.0x)
iRadimed$84M$28M12.8x11.8x38.9x33.1x

This data is available for Pro users. Sign up to see all Wandong Medical competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Wandong Medical

When was Wandong Medical founded?Wandong Medical was founded in 1997.
Where is Wandong Medical headquartered?Wandong Medical is headquartered in China.
How many employees does Wandong Medical have?As of today, Wandong Medical has over 964 employees.
Is Wandong Medical publicly listed?Yes, Wandong Medical is a public company listed on Shanghai Stock Exchange.
What is the stock symbol of Wandong Medical?Wandong Medical trades under 600055 ticker.
When did Wandong Medical go public?Wandong Medical went public in 1997.
Who are competitors of Wandong Medical?Wandong Medical main competitors include Staar Surgical, Artivion, Lumexa Imaging, PHC Holdings, Integra Lifesciences, Guangzhou Wondfo Biotech, PROCEPT BioRobotics, iRadimed, Enovis, Tandem Diabetes Care.
What is the current market cap of Wandong Medical?Wandong Medical's current market cap is $1.1B.
What is the current revenue of Wandong Medical?Wandong Medical's last 12 months revenue is $227M.
What is the current revenue growth of Wandong Medical?Wandong Medical revenue growth (NTM/LTM) is 19%.
What is the current EV/Revenue multiple of Wandong Medical?Current revenue multiple of Wandong Medical is 2.8x.
Is Wandong Medical profitable?No, Wandong Medical is not profitable.
What is the current net income of Wandong Medical?Wandong Medical's last 12 months net income is ($11M).
How many companies Wandong Medical has acquired to date?Wandong Medical hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Wandong Medical has invested to date?Wandong Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Wandong Medical

Lists including Wandong Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial